Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Pain Control in Different Bupivacaine Dose in Periarticular Injection in Bilateral Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged more than 18 years old~* American society of anesthesiologists physical status classification 1-3~* Undergoing bilateral total knee arthroplasty with spinal anesthesia and single shot bilateral adductor canal block~Exclusion Criteria:~* Allergy to bupivacaine~* Body weight less than 50 kilograms~* Hepatic disease~* Coagulopathy~* Creatinine clearance less than 60 ml/min~* Uncontrolled cerebrovascular disease~* Hematocrit less than 35%

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- bupivacaine 100 mg (Type: EXPERIMENTAL): bupivacaine 100 mg ketorolac 30 mg epinephrine 400 mcg add Normal saline solution(NSS) to 80 ml divided to two syringes for bilateral periarticular infiltration
- bupivacaine 200 mg (Type: ACTIVE_COMPARATOR): bupivacaine 200 mg ketorolac 30 mg epinephrine 400 mcg add NSS to 80 ml divided to two syringes for bilateral periarticular infiltration

Based on this trial design, predict the completion outcome and termination type (if applicable).